ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2490

Impact of Obesity Activity Indices and Therapeutic Dosage in Patients with Rheumatoid Arthritis in Dominican Republic

E Rodríguez-Bautista1, V Rosario1, R Peña-Blanco2, R Munoz-Louis1, Y Cruz-Rojas1, I Paulino-Izquierdo1, J Paula-Mateo1, T Valdez-Lorie2 and R Alba-Fériz1, 1Rheumatology, Hospital Docente Padre Billini (HDPB), Santo Domingo, Dominican Republic, 2Rheumatology, Hospital Docente Universitario Dr. Francisco E. Moscoso Puello (HFMP), Santo Domingo, Dominican Republic

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Activity score, obesity and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster III: Treatment – Monitoring, Outcomes, Adverse Events

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic arthritis that mainly affects small and medium joints. It is the most common form of inflammatory arthritis, capable of producing significant joint damage, deformity and functional disability. An association between increased body mass index (BMI) and some inflammatory and autoimmune conditions have been suggested in observational studies. Adipose tissue is considered as an active participant in physiological and pathological processes associated with inflammation and immunity. Evidence suggests that the effect of obesity on joint structure goes beyond overload, which is based on multiple complex factors such as cytokines, hormones, growth factors and intracellular regulators that can modify the course of disease and clinical response; so we set as main objective to assess activity indices in patients with rheumatoid arthritis and its relationship with BMI.

Methods: Descriptive cross-sectional study, in which 3,858 patient records were analyzed in the period from January 2012 to January 2016; 1,235 met RA criteria by the American College of Rheumatology (ACR) 2010, 131 patients met criteria for inclusion, it was assessed patient’s age, sex, BMI, index of disease activity in 28 joints (DAS28), erythrocyte sedimentation rate, disease-modifying drugs (DMARDs) and glucocorticoids, data was obtained in the second visit. SPSS V.22 was employed for Windows 8, developing a database with the aforementioned variables, descriptive statistical analysis was performed with frequencies and percentages, crossed tables were made to establish association between different variables and finally to analyze age, mean and standard deviation (SD) were used.

Results: Females accounted for 96.2%, the average age was 56.48 ± 12 years, 33.5% of patients were overweight, 11.5% obesity class I, class II obesity for a 5.3%, 0.8% class III obesity; 51.1% had a BMI above normal levels; 48.9% were in normal range, 6% achieved remission in normal weight and 1.5% in the scale of overweight; in terms of low activity in normal weight was 6.6% versus 6% with high BMI; 29% was found in moderate activity in normal weight and 22.9% in the high BMI, 10% in normal weight had high activity, compared with 18% of increased BMI patients, the DMARD most used was methotrexate, the most common glucocorticoid used was prednisone.

Conclusion: In our population, we found that higher BMI limits the possibility of achieving low activity or remission and increased BMI was associated with higher doses of DMARDs and glucocorticoids. Prospective studies with more patients, longer follow-up are necessary and remind patients the importance of maintaining an adequate body mass index for better control of their disease.


Disclosure: E. Rodríguez-Bautista, None; V. Rosario, None; R. Peña-Blanco, None; R. Munoz-Louis, None; Y. Cruz-Rojas, None; I. Paulino-Izquierdo, None; J. Paula-Mateo, None; T. Valdez-Lorie, None; R. Alba-Fériz, None.

To cite this abstract in AMA style:

Rodríguez-Bautista E, Rosario V, Peña-Blanco R, Munoz-Louis R, Cruz-Rojas Y, Paulino-Izquierdo I, Paula-Mateo J, Valdez-Lorie T, Alba-Fériz R. Impact of Obesity Activity Indices and Therapeutic Dosage in Patients with Rheumatoid Arthritis in Dominican Republic [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/impact-of-obesity-activity-indices-and-therapeutic-dosage-in-patients-with-rheumatoid-arthritis-in-dominican-republic/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-obesity-activity-indices-and-therapeutic-dosage-in-patients-with-rheumatoid-arthritis-in-dominican-republic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology